Ranked third in the world in terms of volume, the Indian pharmaceutical industry is mainly dominated by foreign players having subsidiaries in India, though purely Indian pharma companies are also present on the scene. With more than 74 US FDA-approved manufacturing facilities, and a current turnover of $12 billion, the pharmaceutical sector in India has an increasing need for competent professionals.

Worth around $100 billion, the Indian healthcare industry is expected to grow to $280 billion by 2020, with a CAGR of 22.9 per cent. One of the major challenges faced by this industry is the lack of qualified professionals and there is immense scope to bridge this skill gap and change the face of the industry.